Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8825790 | Revista Española de Medicina Nuclear e Imagen Molecular | 2017 | 6 Pages |
Abstract
The high rate of hypothyroidism obtained with high doses of 131I in hyperthyroidism secondary to nodular goitre treatment suggests that lower doses might be sufficient to control the disease without an increase in treatment failures. Only patients with positive autoimmunity, in previous anti-thyroid medication, and perhaps male gender in MNG might be given higher doses, as the failure rate increases, but further studies are required.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
O. Tabuenca-Dopico, R. Boente-Varela, J.L. Lamas-Ferreiro,